- Home
- PFIE vs ENTA Comparison
PFIE vs ENTA Comparison
Compare PFIE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFIE
- ENTA
- Stock Information
- Founded
- PFIE 2002
- ENTA 1995
- Country
- PFIE United States
- ENTA United States
- Employees
- PFIE N/A
- ENTA N/A
- Industry
- PFIE Oil & Gas Production
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- PFIE Energy
- ENTA Health Care
- Exchange
- PFIE Nasdaq
- ENTA Nasdaq
- Market Cap
- PFIE 116.4M
- ENTA 127.8M
- IPO Year
- PFIE N/A
- ENTA 2013
- Fundamental
- Price
- PFIE $2.53
- ENTA $5.79
- Analyst Decision
- PFIE Hold
- ENTA Buy
- Analyst Count
- PFIE 1
- ENTA 4
- Target Price
- PFIE $2.55
- ENTA $19.50
- AVG Volume (30 Days)
- PFIE 308.2K
- ENTA 464.3K
- Earning Date
- PFIE 11-06-2024
- ENTA 02-05-2025
- Dividend Yield
- PFIE N/A
- ENTA N/A
- EPS Growth
- PFIE N/A
- ENTA N/A
- EPS
- PFIE 0.19
- ENTA N/A
- Revenue
- PFIE $60,020,217.00
- ENTA $67,635,000.00
- Revenue This Year
- PFIE $4.26
- ENTA $11.80
- Revenue Next Year
- PFIE $8.74
- ENTA $3.99
- P/E Ratio
- PFIE $13.31
- ENTA N/A
- Revenue Growth
- PFIE 3.20
- ENTA N/A
- 52 Week Low
- PFIE $1.33
- ENTA $5.84
- 52 Week High
- PFIE $2.55
- ENTA $17.80
- Technical
- Relative Strength Index (RSI)
- PFIE 68.20
- ENTA 24.81
- Support Level
- PFIE $1.50
- ENTA $5.84
- Resistance Level
- PFIE $2.55
- ENTA $6.56
- Average True Range (ATR)
- PFIE 0.01
- ENTA 0.73
- MACD
- PFIE -0.02
- ENTA -0.18
- Stochastic Oscillator
- PFIE 62.50
- ENTA 2.67
About PFIE Profire Energy Inc.
Profire Energy Inc is an oilfield technology company operating in the United States. It is engaged in the business of developing combustion management technologies for the oil and gas industry. The company specializes in the creation of burner-management systems, used on a variety of oilfield natural-draft fire tube vessels. In addition to the burner-management systems, the company also sell complementary oilfield products to its customer. Geographically, the company divides its business into two business unit namely the United States and Canada and majority of its revenue comes from the United States.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.